Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUNLUN ENERGY
00135
5
CHINA OILFIELD
02883
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -3,237.25%-20.55M | ---- | 102.00%655K | ---- | -1,163.44%-32.72M | ---- | 2,672.07%3.08M | ---- | -83.38%111K |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 4.20%-137K | ---- | 19.66%-143K | ---- | -37.98%-178K | ---- | 3.73%-129K | ---- | 3.60%-134K |
| Impairment and provisions: | ---- | 1,110,350.00%22.21M | ---- | --2K | ---- | ---- | ---- | -2.40%1.3M | ---- | 448.15%1.33M |
| -Impairment of trade receivables (reversal) | ---- | 1,110,350.00%22.21M | ---- | --2K | ---- | ---- | ---- | -2.40%1.3M | ---- | 448.15%1.33M |
| Asset sale loss (gain): | ---- | ---30K | ---- | ---- | ---- | ---- | ---- | 294.44%245K | ---- | -447.83%-126K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---30K | ---- | ---- | ---- | ---- | ---- | 294.44%245K | ---- | -447.83%-126K |
| Depreciation and amortization: | ---- | 4.83%12.86M | ---- | 24.86%12.27M | ---- | -18.44%9.83M | ---- | 5.80%12.05M | ---- | 5.82%11.39M |
| -Depreciation | ---- | 4.83%12.86M | ---- | 24.86%12.27M | ---- | -18.44%9.83M | ---- | 5.80%12.05M | ---- | 5.82%11.39M |
| Financial expense | ---- | -1.54%1.73M | ---- | 4.39%1.76M | ---- | 23.10%1.68M | ---- | -38.29%1.37M | ---- | -7.47%2.22M |
| Special items | ---- | ---- | ---- | ---1K | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit before the change of operating capital | ---- | 10.63%16.09M | ---- | 167.98%14.54M | ---- | -219.44%-21.39M | ---- | 21.10%17.91M | ---- | 6.33%14.79M |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | ---- | -209.45%-18.46M | ---- | 13.04%16.87M | ---- | 167.59%14.92M | ---- | -225.88%-22.08M | ---- | 315.82%17.54M |
| Accounts payable increase (decrease) | ---- | 138.80%14.26M | ---- | -116.67%-36.74M | ---- | -163.73%-16.96M | ---- | 160.22%26.61M | ---- | -431.07%-44.18M |
| prepayments (increase)decrease | ---- | -34.01%421K | ---- | 343.51%638K | ---- | 61.07%-262K | ---- | -122.84%-673K | ---- | 207.75%2.95M |
| Special items for working capital changes | ---- | -168.64%-24.55M | ---- | 47.71%35.77M | ---- | 800.26%24.22M | ---- | -89.18%2.69M | ---- | 187.41%24.86M |
| Cash from business operations | ---- | -139.43%-12.25M | ---- | 5,741.73%31.08M | ---- | -97.82%532K | ---- | 53.23%24.45M | ---- | 232.40%15.96M |
| Other taxs | ---- | ---- | ---- | -745.00%-169K | ---- | -5.26%-20K | ---- | -100.75%-19K | ---- | --2.53M |
| Special items of business | 77.62%-5.31M | ---- | -12,577.54%-23.71M | ---- | 96.36%-187K | ---- | -138.70%-5.13M | ---- | 125.47%13.26M | ---- |
| Net cash from operations | 77.62%-5.31M | -139.65%-12.25M | -12,577.54%-23.71M | 5,936.91%30.91M | 96.36%-187K | -97.90%512K | -138.70%-5.13M | 32.13%24.43M | 125.47%13.26M | 253.43%18.49M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -4.20%137K | ---- | -19.66%143K | ---- | 37.98%178K | ---- | -3.73%129K | ---- | -3.60%134K |
| Sale of fixed assets | ---- | --30K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -8.10%193K |
| Purchase of fixed assets | -40.00%-140K | 93.44%-100K | 94.51%-100K | -446.59%-1.53M | 28.39%-1.82M | 94.89%-279K | 59.12%-2.54M | -31.49%-5.46M | 0.56%-6.22M | -137.34%-4.15M |
| Net cash from investment operations | -40.00%-140K | 104.85%67K | 94.51%-100K | -1,268.32%-1.38M | 28.39%-1.82M | 98.10%-101K | 59.12%-2.54M | -39.36%-5.33M | -1.98%-6.22M | -173.14%-3.82M |
| Net cash before financing | 77.12%-5.45M | -141.27%-12.19M | -1,085.61%-23.81M | 7,084.18%29.53M | 73.84%-2.01M | -97.85%411K | -209.04%-7.68M | 30.24%19.1M | 3,314.16%7.04M | 209.03%14.67M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -41.46%32.45M | 13.39%99.11M | 20.29%55.43M | -21.02%87.41M | -31.09%46.08M | 11.71%110.67M | 23.61%66.87M | 5.01%99.06M | -0.28%54.1M | -31.76%94.34M |
| Refund | 6.32%-43.39M | -1.85%-96.3M | 0.96%-46.31M | 10.59%-94.55M | 20.22%-46.76M | 8.11%-105.75M | 8.70%-58.61M | -21.09%-115.08M | -19.21%-64.19M | 26.31%-95.04M |
| Interest paid - financing | 20.05%-650K | 1.54%-1.73M | 14.33%-813K | -4.39%-1.76M | -31.26%-949K | -23.10%-1.68M | 23.57%-723K | 38.29%-1.37M | 11.42%-946K | 7.47%-2.22M |
| Net cash from financing operations | -221.49%-7.65M | 75.79%-2.98M | 326.19%6.3M | -688.43%-12.31M | -140.69%-2.78M | 110.66%2.09M | 154.66%6.84M | -112.29%-19.63M | -887.22%-12.52M | -20.42%-9.25M |
| Net Cash | 25.21%-13.1M | -188.09%-15.17M | -265.40%-17.51M | 587.85%17.22M | -475.27%-4.79M | 576.76%2.5M | 84.80%-833K | -109.68%-525K | -268.46%-5.48M | 125.66%5.42M |
| Begining period cash | -50.81%14.69M | 136.25%29.85M | 136.25%29.85M | 24.70%12.64M | 24.70%12.64M | -4.93%10.13M | -4.93%10.13M | 103.51%10.66M | 103.51%10.66M | -80.14%5.24M |
| Cash at the end | -87.12%1.59M | -50.81%14.69M | 57.36%12.34M | 136.25%29.85M | -15.66%7.84M | 24.70%12.64M | 79.57%9.3M | -4.93%10.13M | 38.11%5.18M | 103.51%10.66M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.